On August 31, 2022, the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) of the Moderna COVID-19 vaccine and the Pfizer-BioNTech COVID-19 vaccine to authorize the use of bivalent COVID-19 vaccines manufactured by both the companies as a single booster dose. These bivalent vaccines contain the mRNA components of both the…